Gyrus launches large version of BPH (benign prostatic hyperplasia) loop:
This article was originally published in Clinica
UK firm Gyrus has launched a new, larger version of its Plasma-Sect Loop for the treatment of benign prostatic hyperplasia through transurethral resection. The 4mm loop, which is powered by the firm's PlasmaKinetic Tissue Management System, allows surgeons to remove larger prostates faster, meaning less time in the operating room and speedier patient discharge, says the Reading-based company.
You may also be interested in...
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.